medicaid glp-1 McKee's proposed FY2027 budget drops drugs for weight loss from • Rhode Island Current CMS launching payment model to

But in addition to the oral compound, the branded medications, the personalized GLP-1 doses, which augment the commercially available dosages for patients that need it as well as off-patent GLP-1s like liraglutide, I think we believe the combination of that portfolio, allows customers and providers a really robust range of offerings that we think is very durable

Batista AF, Bodart-Santos V, De Felice FG, Ferreira ST

This shifting landscape presents both challenges and opportunities for food manufacturers and suppliers as they adapt to changing consumer interests and emerging functional health priorities

Neuroscience 77 , 257270 (1997)

Additionally, GLP1 has been associated with a reduction in the risk of cardiovascular events in people with obesity, suggesting potential benefits beyond weight loss alone

There are some important clues, though